Metastatic triple-negative breast cancer
Clinical trials for Metastatic triple-negative breast cancer explained in plain language.
Never miss a new study
Get alerted when new Metastatic triple-negative breast cancer trials appear
Sign up with your email to follow new studies for Metastatic triple-negative breast cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill takes on tough breast cancer in first human trial
Disease control Not yet recruitingThis early-phase trial tests an oral drug called Zn-Telomir in 76 adults with advanced or metastatic triple-negative breast cancer that has worsened after prior treatments. The study has two parts: first, finding a safe dose, and second, checking if the drug shrinks tumors. It is…
Matched conditions: METASTATIC TRIPLE-NEGATIVE BREAST CANCER
Phase 1/2 • Sponsor: Telomir Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for black caribbean women with aggressive breast cancer: could a different chemo drug work better?
Disease control Not yet recruitingThis study compares two chemotherapy drugs—gemcitabine and paclitaxel—in Black Caribbean women with metastatic triple-negative breast cancer. The goal is to see if gemcitabine, usually used later, works better as a first treatment. 750 women from Jamaica, Trinidad, and Barbados w…
Matched conditions: METASTATIC TRIPLE-NEGATIVE BREAST CANCER
Phase 2 • Sponsor: AntiCancer Research Jamaica • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC